| Literature DB >> 26091374 |
Xiongbing Tu1, Jie Wang1, Kun Hao1, Douglas W Whitman2, Yaoli Fan1, Guangchun Cao1, Zehua Zhang1.
Abstract
Low temperature induces diapause in locusts. However, the physiological processes and initiation mechanism of diapause are not well understood. To understand the molecular basis of diapause, 'omics' analyses were performed to examine the differences between diapause and non-diapause eggs at both transcriptional and translational levels. Results indicated that a total of 62,241 mRNAs and 212 proteins were differentially expressed. Among them, 116 transcripts had concurrent transcription and translation profiles. Up-regulated genes related to diapause included glutathiones-S-transferase et al., and down-regulated genes including juvenile hormone esterase-like protein et al. KEGG analysis mapped 7,243 and 99 differentially expressed genes and proteins, to 83 and 25 pathways, respectively. Correlation enriched pathways indicated that there were nine identical pathways related to diapause. Gene Ontology analysis placed these genes and proteins into three categories, and a higher proportion of genes related to metabolism was up-regulated than down-regulated. Furthermore, three up-regulated pathways were linked to cryoprotection. This study demonstrates the applicability of high-throughput omics tools to identify molecules linked to diapause in the locust. In addition, it reveals cellular metabolism in diapause eggs is more active than in non-diapause eggs, and up-regulated enzymes may play roles in cryoprotection and storing energy for diapause and post-diapause stages.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26091374 PMCID: PMC4650673 DOI: 10.1038/srep11402
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Summary of RNA-seq metrics from locust eggs transcriptomes.
| Clean Reads | 135,882,798 | 138,727,698 |
| Nucleotides (nt) | 12,229,451,820 | 12,485,492,820 |
| Contig | 210,692 | 223,501 |
| Unigene | 94,118 | 118,651 |
| Total Unigene | 100,490 | |
| Annotation | 36,765 |
Summary of iTRAQ metrics form locust eggs proteomes.
| Total spectra | 271,628 |
| Unique spectra | 8,614 |
| Matched protein | 1,078 |
| Differentially expressed protein | 212 |
Figure 1Statistics of Differentially Expressed Genes and Proteins.
(A)The distribution of differentially expressed genes (DEGs). (B) The distribution of differentially expressed proteins. The X-axis indicates control-vs-treat, and the Y-axis indicates the number of the DEGs or proteins. The red bar indicates up-regulated genes or proteins, and the green bar indicates down-regulated genes or proteins.
Figure 2Expression levels in diapause vs non-diapause locust eggs.
Genes were divided among three classes:red genes are up-regulated in the right sample vs. the left sample, green genes are down-regulated in the right samplevs. the left sample, and blue genes are not differentially expressed. The horizontal coordinate indicatesexpression level in non-diapause eggs, while the vertical coordinates indicate expression level in diapause eggs.
Figure 3Gene Ontological classification of differentially expressed genes and proteins between Non-diapause and Diapause locust eggs.
The differentially expressed genes or proteins are grouped into three hierarchically structured GO terms, biological process, cellular component, and molecular function. The y-axis indicates the number of genes or proteins in each GO term. (A) Differentially expressed genes identified by RNA-seq. (B) Differentially expressed proteins identified by iTRAQ.
Significantly enriched KEGG pathways in transcriptome.
| 1 | Vibrio cholerae infection | 721 (5.14%) | 887 (3.9%) | 4.32E-38 |
| 2 | Metabolic pathways | 2825 (20.13%) | 4089 (17.96%) | 6.11E-28 |
| 3 | Amoebiasis | 650 (4.63%) | 856 (3.76%) | 1.14E-19 |
| 4 | Ribosome | 670 (4.77%) | 923 (4.05%) | 6.61E-13 |
| 5 | Peroxisome | 305 (2.17%) | 400 (1.76%) | 2.81E-10 |
| 6 | Glyoxylate and dicarboxylate metabolism | 164 (1.17%) | 201 (0.88%) | 6.65E-10 |
| 7 | Fatty acid metabolism | 198 (1.41%) | 249 (1.09%) | 8.99E-10 |
| 8 | Proteasome | 203 (1.45%) | 258 (1.13%) | 2.95E-09 |
| 9 | Salivary secretion | 280 (1.99%) | 370 (1.63%) | 5.70E-09 |
| 10 | Prion diseases | 159 (1.13%) | 198 (0.87%) | 1.11E-08 |
| 11 | Synaptic vesicle cycle | 175 (1.25%) | 224 (0.98%) | 9.04E-08 |
| 12 | Collecting duct acid secretion | 94 (0.67%) | 111 (0.49%) | 9.05E-08 |
| 13 | Valine, leucine and isoleucine degradation | 216 (1.54%) | 283 (1.24%) | 9.45E-08 |
| 14 | Rheumatoid arthritis | 113 (0.81%) | 137 (0.6%) | 9.48E-08 |
| 15 | Oxidative phosphorylation | 352 (2.51%) | 485 (2.13%) | 2.09E-07 |
| 16 | Shigellosis | 267 (1.9%) | 360 (1.58%) | 2.97E-07 |
| 17 | Alanine, aspartate and glutamate metabolism | 164 (1.17%) | 211 (0.93%) | 4.18E-07 |
| 18 | Antigen processing and presentation | 133 (0.95%) | 167 (0.73%) | 4.28E-07 |
| 19 | PPAR signaling pathway | 191 (1.36%) | 250 (1.1%) | 4.54E-07 |
| 20 | Epithelial cell signaling in Helicobacter pylori infection | 156 (1.11%) | 200 (0.88%) | 5.34E-07 |
| 21 | Bacterial invasion of epithelial cells | 282 (2.01%) | 386 (1.7%) | 1.31E-06 |
| 22 | Fructose and mannose metabolism | 142 (1.01%) | 183 (0.8%) | 2.90E-06 |
| 23 | Glycolysis/Gluconeogenesis | 227 (1.62%) | 307 (1.35%) | 3.26E-06 |
| 24 | Phagosome | 305 (2.17%) | 423 (1.86%) | 3.39E-06 |
| 25 | Renin-angiotensin system | 43 (0.31%) | 47 (0.21%) | 4.10E-06 |
| 26 | Pathogenic Escherichia coli infection | 315 (2.24%) | 441 (1.94%) | 8.89E-06 |
| 27 | Butanoate metabolism | 101 (0.72%) | 127 (0.56%) | 1.15E-05 |
| 28 | Propanoate metabolism | 149 (1.06%) | 198 (0.87%) | 3.32E-05 |
| 29 | Melanogenesis | 162 (1.15%) | 219 (0.96%) | 7.59E-05 |
| 30 | Arginine and proline metabolism | 202 (1.44%) | 279 (1.23%) | 9.67E-05 |
| 31 | Pyruvate metabolism | 214 (1.52%) | 297 (1.3%) | 9.90E-05 |
| 32 | Parkinson’s disease | 331 (2.36%) | 474 (2.08%) | 0.000105848 |
| 33 | Tyrosine metabolism | 140 (1%) | 188 (0.83%) | 0.000134091 |
| 34 | Glycine, serine and threonine metabolism | 127 (0.9%) | 169 (0.74%) | 0.000136795 |
| 35 | Citrate cycle (TCA cycle) | 204 (1.45%) | 284 (1.25%) | 0.000189872 |
| 36 | Tryptophan metabolism | 137 (0.98%) | 185 (0.81%) | 0.000241699 |
| 37 | beta-Alanine metabolism | 127 (0.9%) | 171 (0.75%) | 0.000326199 |
| 38 | Synthesis and degradation of ketone bodies | 37 (0.26%) | 43 (0.19%) | 0.000428008 |
| 39 | Legionellosis | 156 (1.11%) | 215 (0.94%) | 0.000485139 |
| 40 | Riboflavin metabolism | 36 (0.26%) | 42 (0.18%) | 0.000602506 |
| 41 | GABAergic synapse | 125 (0.89%) | 171 (0.75%) | 0.001053885 |
| 42 | Dopaminergic synapse | 179 (1.28%) | 252 (1.11%) | 0.0010958 |
| 43 | MAPK signaling pathway | 308 (2.19%) | 449 (1.97%) | 0.001181529 |
| 44 | Tuberculosis | 242 (1.72%) | 348 (1.53%) | 0.001212063 |
| 45 | Adipocytokine signaling pathway | 103 (0.73%) | 139 (0.61%) | 0.001311472 |
| 46 | Measles | 160 (1.14%) | 224 (0.98%) | 0.001326528 |
| 47 | Influenza A | 327 (2.33%) | 479 (2.1%) | 0.001386636 |
| 48 | Epstein-Barr virus infection | 515 (3.67%) | 772 (3.39%) | 0.001735867 |
| 49 | Wnt signaling pathway | 228 (1.62%) | 329 (1.45%) | 0.002178141 |
| 50 | Starch and sucrose metabolism | 154 (1.1%) | 217 (0.95%) | 0.002486196 |
| 51 | Alzheimer’s disease | 354 (2.52%) | 526 (2.31%) | 0.003783211 |
| 52 | Amino sugar and nucleotide sugar metabolism | 156 (1.11%) | 223 (0.98%) | 0.005776157 |
| 53 | Amphetamine addiction | 99 (0.71%) | 137 (0.6%) | 0.005909079 |
| 54 | Pertussis | 76 (0.54%) | 103 (0.45%) | 0.006425784 |
| 55 | Pentose phosphate pathway | 108 (0.77%) | 151 (0.66%) | 0.006995646 |
| 56 | Adherens junction | 274 (1.95%) | 406 (1.78%) | 0.008035088 |
| 57 | Phototransduction - fly | 82 (0.58%) | 113 (0.5%) | 0.009757659 |
| 58 | Toxoplasmosis | 169 (1.2%) | 245 (1.08%) | 0.009908632 |
| 59 | HTLV-I infection | 351 (2.5%) | 528 (2.32%) | 0.01145809 |
| 60 | Insulin signaling pathway | 241 (1.72%) | 358 (1.57%) | 0.01451352 |
| 61 | Primary bile acid biosynthesis | 40 (0.28%) | 52 (0.23%) | 0.0146295 |
| 62 | Endocrine and other factor-regulated calcium reabsorption | 89 (0.63%) | 125 (0.55%) | 0.01622075 |
| 63 | Huntington’s disease | 589 (4.2%) | 905 (3.98%) | 0.01628533 |
| 64 | Osteoclast differentiation | 77 (0.55%) | 107 (0.47%) | 0.01652479 |
| 65 | Retinol metabolism | 100 (0.71%) | 142 (0.62%) | 0.01807061 |
| 66 | Glycerolipid metabolism | 162 (1.15%) | 237 (1.04%) | 0.0185793 |
| 67 | Pentose and glucuronate interconversions | 147 (1.05%) | 214 (0.94%) | 0.01893007 |
| 68 | Alcoholism | 169 (1.2%) | 248 (1.09%) | 0.01942268 |
| 69 | Biosynthesis of unsaturated fatty acids | 80 (0.57%) | 112 (0.49%) | 0.01948457 |
| 70 | Protein processing in endoplasmic reticulum | 430 (3.06%) | 656 (2.88%) | 0.02020514 |
| 71 | Pancreatic secretion | 192 (1.37%) | 284 (1.25%) | 0.02119797 |
| 72 | Valine, leucine and isoleucine biosynthesis | 34 (0.24%) | 44 (0.19%) | 0.02127704 |
| 73 | alpha-Linolenic acid metabolism | 67 (0.48%) | 93 (0.41%) | 0.02344569 |
| 74 | Phenylalanine metabolism | 72 (0.51%) | 101 (0.44%) | 0.02755099 |
| 75 | Endocytosis | 363 (2.59%) | 554 (2.43%) | 0.03150932 |
| 76 | Vitamin B6 metabolism | 16 (0.11%) | 19 (0.08%) | 0.03185256 |
| 77 | Glutathione metabolism | 126 (0.9%) | 184 (0.81%) | 0.03210199 |
| 78 | Arachidonic acid metabolism | 71 (0.51%) | 100 (0.44%) | 0.03246063 |
| 79 | Retrograde endocannabinoid signaling | 94 (0.67%) | 135 (0.59%) | 0.03279646 |
| 80 | Fc gamma R-mediated phagocytosis | 313 (2.23%) | 476 (2.09%) | 0.03438166 |
| 81 | Nicotine addiction | 34 (0.24%) | 45 (0.2%) | 0.03585109 |
| 82 | Terpenoid backbone biosynthesis | 58 (0.41%) | 81 (0.36%) | 0.03984046 |
| 83 | Galactose metabolism | 99 (0.71%) | 144 (0.63%) | 0.04608303 |
Figure 4Correlation between differently expressed proteins and genes.
The numerical value in each circle represents the quantity of genes or proteins, including identified genes and proteins and genes or proteins related to diapause, respectively, and genes/proteins related to diapause together.
Figure 5Variation intrends between differentially expressed mRNA and protein from the same locus.
(A) represents differentially expressed mRNA and protein with the same trend, while (B) represents differentially expressed mRNA and protein with opposite trends.Scatter plots illustrate the distribution of differentially expressed proteins and related genes. The Pearson correlation coefficient between protein and mRNA expression profiles is shown in the upper left corner of the plot.
Significantly enriched KEGG pathways in proteome.
| 1 | Metabolism of xenobiotics by cytochrome P450 | 10 (5.41%) | 15 (1.69%) | 0.000141533 |
| 2 | Metabolic pathways | 60 (32.43%) | 201 (22.66%) | 0.000365654 |
| 3 | Riboflavin metabolism | 11 (5.95%) | 20 (2.25%) | 0.000706352 |
| 4 | Drug metabolism - cytochrome P450 | 8 (4.32%) | 12 (1.35%) | 0.000714683 |
| 5 | Melanogenesis | 13 (7.03%) | 26 (2.93%) | 0.000759894 |
| 6 | Tyrosine metabolism | 12 (6.49%) | 25 (2.82%) | 0.001936295 |
| 7 | Peroxisome | 10 (5.41%) | 19 (2.14%) | 0.001966556 |
| 8 | Prostate cancer | 7 (3.78%) | 12 (1.35%) | 0.004713203 |
| 9 | Other glycan degradation | 4 (2.16%) | 5 (0.56%) | 0.007708014 |
| 10 | Lysosome | 12 (6.49%) | 30 (3.38%) | 0.0118856 |
| 11 | Drug metabolism - other enzymes | 5 (2.7%) | 8 (0.9%) | 0.01213747 |
| 12 | Alcoholism | 6 (3.24%) | 11 (1.24%) | 0.0137955 |
| 13 | Retinol metabolism | 4 (2.16%) | 6 (0.68%) | 0.0193596 |
| 14 | Ascorbate and aldarate metabolism | 4 (2.16%) | 6 (0.68%) | 0.0193596 |
| 15 | Glyoxylate and dicarboxylate metabolism | 5 (2.7%) | 9 (1.01%) | 0.02273707 |
| 16 | Glutathione metabolism | 8 (4.32%) | 19 (2.14%) | 0.02806231 |
| 17 | Aldosterone-regulated sodium reabsorption | 3 (1.62%) | 4 (0.45%) | 0.03029416 |
| 18 | Steroid hormone biosynthesis | 3 (1.62%) | 4 (0.45%) | 0.03029416 |
| 19 | Pentose and glucuronate interconversions | 5 (2.7%) | 10 (1.13%) | 0.03790488 |
| 20 | Regulation of actin cytoskeleton | 8 (4.32%) | 20 (2.25%) | 0.03861341 |
| 21 | Mineral absorption | 2 (1.08%) | 2 (0.23%) | 0.04331439 |
| 22 | Acute myeloid leukemia | 2 (1.08%) | 2 (0.23%) | 0.04331439 |
| 23 | Endometrial cancer | 2 (1.08%) | 2 (0.23%) | 0.04331439 |
| 24 | Carbohydrate digestion and absorption | 2 (1.08%) | 2 (0.23%) | 0.04331439 |
| 25 | Salmonella infection | 7 (3.78%) | 17 (1.92%) | 0.04466544 |